P17.03.A MAGIC-G1: A PHASE 1 DOSE-ESCALATION TRIAL OF WEEKLY INTRATUMORAL ADMINISTRATION OF THE SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM)
Conferences
Desjardins, A; Barnes, H; Davies, R; Grant, G; Cavaliere, R; Sauvageau, E; Zamoryakhin, D
Published in: Neuro-Oncology
September 8, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
September 8, 2023
Volume
25
Issue
Supplement_2
Start / End Page
ii117 / ii117
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Barnes, H., Davies, R., Grant, G., Cavaliere, R., Sauvageau, E., & Zamoryakhin, D. (2023). P17.03.A MAGIC-G1: A PHASE 1 DOSE-ESCALATION TRIAL OF WEEKLY INTRATUMORAL ADMINISTRATION OF THE SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM). In Neuro-Oncology (Vol. 25, pp. ii117–ii117). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noad137.393
Desjardins, A., H. Barnes, R. Davies, G. Grant, R. Cavaliere, E. Sauvageau, and D. Zamoryakhin. “P17.03.A MAGIC-G1: A PHASE 1 DOSE-ESCALATION TRIAL OF WEEKLY INTRATUMORAL ADMINISTRATION OF THE SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM).” In Neuro-Oncology, 25:ii117–ii117. Oxford University Press (OUP), 2023. https://doi.org/10.1093/neuonc/noad137.393.
Desjardins A, Barnes H, Davies R, Grant G, Cavaliere R, Sauvageau E, et al. P17.03.A MAGIC-G1: A PHASE 1 DOSE-ESCALATION TRIAL OF WEEKLY INTRATUMORAL ADMINISTRATION OF THE SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM). In: Neuro-Oncology. Oxford University Press (OUP); 2023. p. ii117–ii117.
Desjardins, A., et al. “P17.03.A MAGIC-G1: A PHASE 1 DOSE-ESCALATION TRIAL OF WEEKLY INTRATUMORAL ADMINISTRATION OF THE SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM).” Neuro-Oncology, vol. 25, no. Supplement_2, Oxford University Press (OUP), 2023, pp. ii117–ii117. Crossref, doi:10.1093/neuonc/noad137.393.
Desjardins A, Barnes H, Davies R, Grant G, Cavaliere R, Sauvageau E, Zamoryakhin D. P17.03.A MAGIC-G1: A PHASE 1 DOSE-ESCALATION TRIAL OF WEEKLY INTRATUMORAL ADMINISTRATION OF THE SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM). Neuro-Oncology. Oxford University Press (OUP); 2023. p. ii117–ii117.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
September 8, 2023
Volume
25
Issue
Supplement_2
Start / End Page
ii117 / ii117
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis